Home » today » Health » COVID-19: more than 2 million AstraZeneca vaccines will expire at the end of March, warns former minister Ugarte | Synopharm | COVID-19 | NMR | PERU

COVID-19: more than 2 million AstraZeneca vaccines will expire at the end of March, warns former minister Ugarte | Synopharm | COVID-19 | NMR | PERU

The former Minister of Health, Óscar Ugarte, warned that at the end of March more than two million vaccines against the coronavirus (COVID-19) from the AstraZeneca laboratory will expire. In addition, he recalled that last February just over a million doses of the British pharmaceutical company were lost.

“There is a population to be vaccinated, there is a need for the third dose. We have vaccines, but what is happening. Vaccines are expiring. At the end of February, a little over a million doses of AstraZeneca vaccines have expired, which are probably for the third dose. Now at the end of March, in one week, more than 2 million AstraZeneca vaccines are due that are not being applied and that we are going to lose, he asserted in a dialogue with RPP Noticias.

He also added that the latest vaccines from the Sinopharm laboratory acquired in September 2021, during the management of the former Minister of Health, Hernando Cevallos, are also close to expiring.

COVID-19: more than 2 million AstraZeneca vaccines are about to expire at the end of March, warns former minister Ugarte

“The Sinopharm vaccine was 8 million, of those only two million have been applied. In other words, there are 6 million from Sinopharm that must be expiring, also because that is the maximum term in which the vaccines arrive “, he specified. “So we have AstraZeneca vaccines that are expiring, we have Sinopharm vaccines that are expiring.”he added.

Minsa confirms disagreements with AstraZeneca

At the end of January, Hernando Cevallos pointed out that Peru would receive a large number of doses from AstraZeneca with expiration dates of less than six months. He explained that the contract was signed on December 31, 2020, during the management of Francisco Sagasti, and that despite not meeting the delivery dates, no penalty is contemplated for the British pharmaceutical company if it fails to comply with the agreement.

When asked about to a possible international legal claim against the AstraZeneca laboratorythe official stated that to date they have been looking for solutions: find countries that accept the donation of these batches of vaccines against COVID-19, despite the fact that some nations have already expressed that they will not be able to accept this support due to the short expiration date of the doses.

“In December 2020, the previous government signs an agreement with AstraZeneca for about 14 million vaccines. Contracts in general have clauses that clearly favor companies. They are contracts of a confidential nature, which is a disadvantage for the recipient country of the vaccines where delivery times are indicated, which, in this case, was mostly from the month of September and deadlines are also indicated for the expiration of the products. what In my opinion, they are absolutely abusive and do not allow countries to manage them with more logical health criteria”He commented at the time.

Dose application decrease

The former head of Immunizations of the Minsa, Gabriela Jiménez, pointed out last Thursday that the progress in the vaccination process decreased during the first 15 days of March.

In a dialogue with RPP Noticias, he recalled that up to the end of February, 63 million 50 thousand doses had been administered. We have made a calculation where we compared the speed of the vaccine that we have had in the first 58 days of 2022 starting from January 1 to February 28. (…) So the daily vaccination average was 210,000 a day”.

“In that scenario, we had a speed of the third dose of 111 thousand vaccinated per day. However, when we are now reviewing the figures corresponding to the first 15 days of March, we find that the rate of vaccination in the third-dose vaccination group has fallen by an average/day of 56,000, from what we used to do to 111,000, which leads us to a negative variation rate of -50%. And when we see the vaccines in the first doses of daily production that we had from 52,000 to 53,000, we have fallen to a daily average of 31,000, we are talking about a negative variation rate of -38% “he detailed.

RECOMMENDED VIDEO

Minsa does not rule out a fourth wave due to a delay in vaccination against COVID-19
The Ministry of Health indicates that citizens over 18 years of age still do not have their third dose, in this way, they hope to reach 70% of objective vaccination. (Source: Latin TV) https://www.latina.pe/noticias

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.